The impact of mood disorders and their treatment on the pregnant woman, the fetus, and the infant

Current Psychiatry Reports

Volumn 12, Issue 2, 2010, Pages 96-103

  Kloos, Angelica L ^a   Dubin Rhodin, Abigail ^b   Sackett, Jillan Cantor ^c   Dixon, Thomas A ^d   Weller, Ronald A ^e   Weller, Elizabeth B ^e  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bipolar disorder; Depression; Mood disorder; Pregnancy; Treatmen

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; DESIPRAMINE; DOXEPIN; DULOXETINE; ESSENTIAL FATTY ACID; FLUOXETINE; FOLIC ACID; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STRESS HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; VITAMIN K GROUP; ZIPRASIDONE;

ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ADJUVANT THERAPY; AGITATION; AGRANULOCYTOSIS; APGAR SCORE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIRTH DEFECT; BIRTH WEIGHT; BODY TEMPERATURE DISORDER; BREATHING DISORDER; CLEFT PALATE; COGNITIVE THERAPY; CONGENITAL HEART MALFORMATION; CONVULSION; CRANIOFACIAL MALFORMATION; CRYING; CYANOSIS; DEPRESSION; DIGESTIVE SYSTEM DISEASE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG SAFETY; EBSTEIN ANOMALY; ELECTROCARDIOGRAM; ELECTROCONVULSIVE THERAPY; ENDOCRINE DISEASE; EPICANTHUS; EXERCISE; FACE DYSMORPHIA; FEEDING DISORDER; FETAL CARBAMAZEPINE SYNDROME; FETAL VALPROATE SYNDROME; FETUS MORTALITY; FETUS OUTCOME; FETUS RISK; FETUS WEIGHT; FINGERNAIL HYPOPLASIA; HEAD CIRCUMFERENCE; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INTERPERSONAL THERAPY; IRRITABILITY; LETHARGY; LIP MALFORMATION; LIVER TOXICITY; LOW BIRTH WEIGHT; MAJOR DEPRESSION; MANIA; MASSAGE; METABOLIC DISORDER; MICROGNATHIA; MOOD DISORDER; MOTOR DYSFUNCTION; MOUTH MALFORMATION; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; MUSCLE TONE; NERVOUSNESS; NEURAL TUBE DEFECT; NOSE MALFORMATION; NUTRITION; OMPHALOCELE; OSSIFICATION; PATIENT SAFETY; PERSISTENT PULMONARY HYPERTENSION; PHOTOTHERAPY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PSYCHIATRIC TREATMENT; PUERPERIUM; PULMONARY VALVE ATRESIA; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEDATION; SEIZURE; SHIVERING; SIDE EFFECT; SLEEP; SLEEP DISORDER; SOMNOLENCE; SPINA BIFIDA; THROMBOCYTOPENIA; TREMOR; WEIGHT GAIN; YOGA;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; MOOD DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 77953487316     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-010-0098-6     Document Type: Review

References (49)

1. Vesga-Lopez O, Blanco C, Keyes K, et al.: Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008, 65:805-815.
2. Kessler RC, McGonagle KA, Swartz M, et al.: Sex and depression in the National Comorbidity Survey, I: lifetime, prevalence, chronicity, and recurrence. J Affect Disord 1993, 29:85-96.
3. Cohen LS, Altshuler LL, Harlow BL, et al.: Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006, 295:499-507. (Published erratum appears in JAMA 2006, 296:170.)
4. Viguera AC, Whitfield T, Baldessarini RJ, et al.: Risk of reoccurrence in women with bipolar disorder during pregnancy: a prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007, 164:1817-1824.
5. Marcus S: Depression during pregnancy: rates, risks, and consequences. Can J Clin Pharmacol 2009, 16:e15-e22.
6. Mulder EJ, Robles de Medina PG, Huizink AC, et al.: Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev 2002, 70:3-14.
7. Field T: Breastfeeding and antidepressants. Infant Behav Dev 2008, 31:481-487.
8. McLennan JD, Kotelchuck M: Parental prevention practices for young children in the context of maternal depression. Pediatrics 2000, 105:1090-1095.
9. Jennings KD, Ross S, Popper S, Elmore M: Thoughts of harming infants in depressed and nondepressed mothers. J Affect Disord 1999, 54:21-28.
10. Marangell LB: Currents issues: women and bipolar disorder. Dialogues Clin Neurosci 2008, 10:229-238.
11. Viguera AC, Nonacs R, Cohen LS, et al.: Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000, 157:179-184.
12. Pariser SF: Women and mood disorders. Menarche to menopause. Ann Clin Psychiatry 1993, 5:249-254.
13. Miller LJ: Postpartum depression. JAMA 2002, 287:762-765.
14. Hale TW: Medications and Mothers' Milk, edn 13. Amarillo, TX: Hale Publishing; 2008.
15. Einarson A: Risks/safety of psychotropic medication use during pregnancy. Can J Clin Pharmacol 2009 Jan 22 (Epub ahead of print).
16. Sackett JC, Weller RA, Weller EB: Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications. Curr Psychiatry Rep 2009, 11:253-257. This article serves as a reference for physicians so that they can choose the best care and treatment for pregnant and nursing women with mood disorders. This will help physicians to decide whether patients should continue with SSRI medication while pregnant.
17. ACOGCommittee on Obstetric Practice:ACOGCommitteeOpinion No. 354: treatment with selective serotonin reuptake inhibitors during pregnancy. Obstet Gynecol 2006, 108:1601-1603.
18. Källén B, Olausson PO: Maternal use of selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2008, 17:801-806.
19. Hernández-Díaz S, Van Marter LJ, Werler MM, et al.: Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 2007, 120:e272-e282.
20. Oberlander T, Misri S, Fitzgerald C, et al.: Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004, 65:230-237.
21. Davis RL, Rubanowice D, McPhillips H, et al.: Risks of congenital malformations and perinatal events among infants exposed to antidepressant medication during pregnancy. Pharmacoepidemiol Drug Saf 2007, 16:1086-1094.
22. Menon S: Psychotropic medication during pregnancy and lactation. Arch Gynecol Obstet 2008, 277:1-13. This article aids the physician in determining whether patients should continue taking particular psychotropic medications while pregnant. In many cases, Menon makes suggestions about whether a medication should be considered as first-line treatment.
23. Way CM: Safety of newer antidepressants in pregnancy. Pharmacotherapy 2007, 27:546-552.
24. Moses-Kolko EL, Boegn D, Perel J, et al.: Neonatal signs after late in utero exposure to serotonin reuptake inhibitors. JAMA 2005, 293:2372-2383.
25. Kalra S, Einarson A, Koren G: Taking antidepressants during late pregnancy: how should we advise women? Can Fam Physician 2005, 51:1077-1078.
26. Freeman M: Postpartum depression treatment and breastfeeding. Available at http://www.cmeinstitute.com/psychlopedia/depression/ 5mddw/sec2/section.asp. Accessed September 28, 2009.
27. Weissman AM, Levy BT, Hartz AJ, et al.: Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004, 161:1066-1078.
28. Moretti M: Psychotropic drugs in lactation. Can J Clin Pharmacol 2009, 16:e49-e57.
29. Schmidt K, Olesen O, Jensen P: Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 2000, 47:164-165.
30. Whitby DH, Smith KM: The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding. Pharmacotherapy 2005, 25:411-415.
31. Gentile S: The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 2005, 28:137-152.
32. Klier CM, Miossaheb N, Lee A, Zering G: Mirtazapine and breastfeeding: maternal and infant plasma levels. Am J Psychiatry 2007, 164:348-349.
33. Kristensen JH, Ilett KF, Rampono J, et al.: Transfer of the antidepressant mirtazapine into breast milk. Br J Clin Pharmacol 2007, 63:322-327.
34. Dodd S, Berk M: The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperium. Curr Drug Saf 2006, 1:25-33.
35. Weller EB, Kloos AL, Hitchcock S, Weller RA: Are anticonvulsants safe for pediatric bipolar disorder? Curr Psychiatr 2005, 4:31-48.
36. Stowe ZN: The use of mood stabilizers during breastfeeding. J Clin Psychiatry 2007, 68(Suppl 9):22-28.
37. Eberhard-Gran M, Eskild A, Opjordsmoen S: Treating mood disorders during pregnancy: safety considerations. Drug Saf 2005, 28:695-706.
38. Newport DJ, Stowe ZN, Viguera AC, et al.: Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord 2008, 10:432-436.
39. Spinelli MG, Endicott J: Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am J Psychiatry 2003, 160:555-562.
40. Austin MP, Frilingos M, Lumley J, et al.: Brief antenatal cognitive behavior therapy group intervention for the prevention of postnatal depression and anxiety: a randomised controlled trial. J Affect Disord 2008, 105:35-44.
41. Cho HJ, Kwon JH, Lee JJ: Antenatal cognitive-behavioral therapy for prevention of postpartum depression: a pilot study. Yonsei Med J 2008, 49:553-562.
42. Daley A: Exercise and depression: a review of reviews. J Clin Psychol Med Settings 2008, 15:140-147.
43. Shapiro D, Cook IA, Davydov DM, et al.: Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med 2007, 4:493-502.
44. Zhang ZJ, Chen HY, Yip K, et al.: The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord 2009 July 24 (Epub ahead of print).
45. Manber R, Schnyer RN, Allen JJ, et al.: Acupuncture: a promising treatment for depression during pregnancy. J Affect Disord 2004, 83:89-95.
46. Epperson CN, Terman M, Terman JS, et al.: Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry 2004, 65:421-425.
47. Anderson EL, Reti IM: ECT in pregnancy: A review of the literature from 1941 to 2007. Psychosom Med 2009, 71:235-242.
48. Leung BM, Kaplan BJ: Perinatal depression: prevalence, risks, and the nutrition link-a review of the literature. J Am Diet Assoc 2009, 109:1566-1575.
49. ACOG Committee on Practice Bulletins-Obstetrics: ACOG Practice Bulletin: clinical management guidelines for obstetriciangynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008, 111:1001-1020. This comprehensive review published by the American College of Obstetricians and Gynecologists addresses use of all classes of psychiatric medications during pregnancy and lactation. It provides an important perspective for the practicing psychiatrist.